Cardiometabolic Risk: The Role of Intra-Abdominal Adiposity and the Endocannabinoid System
Cardiometabolic Risk: The Role of Intra-Abdominal Adiposity and the Endocannabinoid System
Cardiometabolic Risk Home Intra-Abdominal Adiposity (IAA). A Multitude of Challenges. One Important, Informative Podcast. New Pathways to Cardiometabolic Risk: The Endocannabinoid System (ECS) Cardiometabolic Condition Site
Intra-Abdominal Adiposity (IAA).
A Multitude of Challenges.
One Important, Informative Podcast.

Listen to the Podcast

This Podcast provides eye-opening numbers on the increasing prevalence of obesity and diabetes in the United States, and insights into the ways in which to deal with the challenge. You will find information on different types of adipose tissue, including intra-abdominal adiposity (IAA), and their varying impact on traditional and emerging risk factors. The Podcast discusses the new understanding that IAA is the "high-risk" fat—and why adipose tissue is now considered an endocrine organ. Adipose tissue secretes hormones and other factors that can increase—or decrease—risks for cardiovascular disease and diabetes. The mechanisms of insulin resistance will also be explored, along with techniques to assess and monitor IAA.

Presenter
James Early, MD
Clinical Associate Professor
Department of Preventive Medicine
University of Kansas School of Medicine
Wichita, Kansas

Roundtable Moderator
Jane Jeffrie Seley, NP, CDE
Diabetes Nurse Practitioner
New York Presbyterian - Weill Cornell Center
New York, New York
Roundtable Discussants
Dwight Deter, PA-C
Certified Physician Assistant
Southwest Endocrine Consultants
El Paso, Texas

W. Lane Edwards, MSN, ARNP, ANP
Nurse Practitioner
Partner, Partners in Healthcare Education, LLC
Ft. Myers, Florida

Linda Siminerio, RN, PhD, CDE
Assistant Professor of Medicine
University of Pittsburgh School of Medicine
Director, University of Pittsburgh Diabetes Institute
Pittsburgh, Pennsylvania
Commercial support provided by sanofi-aventis